Publications by authors named "Christian Gill"

Claim this Profile
C
Cefepime failure for the treatment of cefepime-susceptible, KPC-producing emphysematous cystitis.
Jordynne Morelan, Rong Hou, Robin Chamberland, Christian M Gill

ASM Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Risks: Epidemiology of Complicated Pneumococcal Bloodstream Infections.
Nongnooch Poowanawittayakom, Rashini Jayawarden, Robin Chamberland, Christian Gill

Cureus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Meropenem Stability in Meropenem Admixtures Using 2 g Vials and Normal Saline Prepared Using addEASE Connectors.
Christian M Gill, Teresa Sierra, Nicholas Kovarik, Melissa Mays, Thomas Lavoie

Hosp Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
persistence of clinical methicillin-resistant isolates from bone and joint infections after exposure to daptomycin, telavancin, and vancomycin.
Aliaa Fouad, Joseph L Kuti, Christian M Gill

Microbiol Spectr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-operative Infections After Emergent Laparotomy for Traumatic Perforated Viscera: An Assessment of Risk Factors and Antimicrobial Prophylaxis.
Jaime B Befeler, Christian M Gill, John Culhane, Nongnooch Poowanawittayakom

Cureus· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against 72-hour murine thigh infection model.
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, David P Nicolau, Christian M Gill

Infect Dis (Lond)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Intravenous and Inhaled Amikacin Breakpoint Reporting for Complex Pulmonary Isolates.
Christian M Gill, Robin Chamberland, Getahun Abate

Pathogens· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Workflow and Time to Antibiotic Dose Adjustment for Critically Ill Patients Starting Continuous Renal Replacement Therapy.
Megan Fulbright, Robert Sbertoli, Christian M Gill

Hosp Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose optimization of piperacillin/tazobactam, cefepime, and ceftazidime for carbapenem-resistant Pseudomonas aeruginosa isolates in Türkiye.
Ecem Buyukyanbolu, Christian M Gill, Leyla Genc, Mehmet Karakus, Fusun Comert

Eur J Clin Microbiol Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adjunct bezlotoxumab for preventing infection recurrence in patients post - hematopoietic stem cell transplantation.
Mahi Patel, Christian M Gill, Robin Chamberland, Tyler Heflin, Rachel Mehringer

J Oncol Pharm Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenem-Resistant Isolated From a Patient in a Midwestern U.S. Hospital With a History of Indian Travel: Therapeutic Strategies and Clinical Outcomes.
Christopher Phan, Kristen Tsai, Christian M Gill, Robin Chamberland, Christian Hendrix

Case Rep Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactam.
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, David P Nicolau, Christian M Gill

J Antimicrob Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
Emily L Gill, Christian M Gill, Colleen McEvoy

Ann Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, David P Nicolau, Christian M Gill

J Antimicrob Chemother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the Culprit.
Kamilia Abdelraouf, Christian M Gill, Matthew Gethers, Giusy Tiseo, Simona Barnini

Open Forum Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures.
Victor H Ruiz, Christian M Gill, David P Nicolau

J Antimicrob Chemother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
Christian M Gill, Debora Santini, David P Nicolau,

J Antimicrob Chemother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant .
Christian M Gill, Poonam Rajkotia, Amity L Roberts, Fred C Tenover, David P Nicolau

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
Aliaa Fouad, David P Nicolau, Christian M Gill

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
Su Young Lee, Christian M Gill, David P Nicolau,

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
Aliaa Fouad, Christian M Gill, Patricia J Simner, David P Nicolau, Tomefa E Asempa

J Antimicrob Chemother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases.
Yasmeen Abouelhassan, Christian M Gill, David P Nicolau

J Antimicrob Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model.
Christian M Gill, David P Nicolau

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
Christian M Gill, Debora Santini, Miki Takemura, Christopher Longshaw, Yoshinori Yamano

J Antimicrob Chemother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48.
Tomefa E Asempa, Abigail K Kois, Christian M Gill, David P Nicolau

J Antimicrob Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis